nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2025, 12, v.34 945-947
1例老年急性淋巴细胞白血病患者继发肺部感染的抗感染治疗实践
基金项目(Foundation):
邮箱(Email): lilixia@xinhuamed.com.cn;
DOI: 10.19577/j.1007-4406.2025.12.011
发布时间: 2025-12-25
出版时间: 2025-12-25
移动端阅读
摘要:

报道1例老年急性淋巴细胞白血病患者化疗后继发中性粒细胞缺乏,并出现耐碳青霉烯类铜绿假单胞菌(CRPA)与黑曲霉菌肺部感染的抗感染治疗实践过程。患者,男性,65岁,临床诊断为急性淋巴细胞白血病,入院拟行化疗。入院后患者反复发热,临床药师结合检查结果,为患者制订了个体化抗感染治疗方案:针对CRPA感染,采用以多黏菌素B为基础的联合治疗方案;针对黑曲霉菌肺部感染,采用艾沙康唑联合卡泊芬净的治疗方案。通过精准的抗感染策略与及时调整用药方案,该患者2种耐药病原体感染均得到了有效遏制,临床症状与影像学表现均获显著改善。

Abstract:

KeyWords:
参考文献

[1]卫菊,朱秋丽,孙喆,等.碳青霉烯类耐药的铜绿假单胞菌感染对血液病患者病死率的影响[J].中华内科杂志,2020,59(5):353.

[2]GHEZ D, CALLEJA A,PROTIN C,et al.Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib[J].Blood,2018,131(17):1955.

[3]TAMMA P D,AITKEN S L,BONOMO R A,et al.Infectious diseases society of America 2022 guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales(ESBL-E),carbapenem-resistant Enterobacterales(CRE),and Pseudomonas aeruginosa with difficult-to-treat resistance(DTR-P.aeruginosa)[J].Clin Infect Dis,2022,75(2):187.

[4]中华医学会呼吸病学分会感染学组,中国铜绿假单胞菌下呼吸道感染诊治专家共识(2022年版)[J].中华结核和呼吸杂志,2022,45(8):739.

[5]SHI A X,QU Q,ZHUANG H H,et al.Individualized antibiotic dosage regimens for patients with augmented renal clearance[J],Front Pharmacol,2023,14:1137975.

[6]杜宁,夏铮铮,陈土佳,等,1例血流感染的肥胖患者阿米卡星剂量优化的药学服务[J].中国临床药学杂志,2023,32(7):544.

[7]ZENG M,XIA J,ZONG Z Y,et al.Guidelines for the diagnosis,treatment,prevention and control of infections caused by carbapenem-resistant gram-negative bacilli[J].J Microbiol Immunol Infect,2023,56(4):653.

[8]沙佳宇,李莉霞.1例肺脓肿并发真菌和多重耐药细菌感染的药学监护[J].中国临床药学杂志,2024,33(1):66.

[9]于佳鑫,左玮,杨阳,等.多黏菌素类联合其他抗菌药物治疗耐碳青霉烯类革兰阴性菌感染的研究进展[J].临床药物治疗杂志,2022,20(7):1.

[10]PATTERSON T F,THOMPSON G R 3rd,DENNING D W,et al.Practice guidelines for the diagnosis and management of aspergillosis:2016 update by the infectious diseases society of America[J],Clin Infect Dis,2016,63(4):el.

[11]PéREZ-CANTERO A,LóPEZ-FERNáNDEZ L,GUARRO J,et al.Azole resistance mechanisms in Aspergillus:update and recent advances[J].Int J Antimicrob Agents,2020,55(1):105807.

[12]LIU A,XIONG L B,WANG L,et al.Compare the efficacy of antifungal agents as primary therapy for invasive aspergillosis:a network meta-analysis[J].BMC Infect Dis,2024,24(1):581.

[13]RAFFETIN A,COURBIN V,JULLIEN V,et al.In vitro combination of isavuconazole with echinocandins against azolesusceptible and-resistant Aspergillus spp.[J].Antimicrob Agents Chemother,2018,62(1):e01382.

[14]中华医学会血液学分会抗感染学组.艾沙康唑临床应用专家共识(2023版)[J].临床血液学杂志,2023,36(5):295.

基本信息:

DOI:10.19577/j.1007-4406.2025.12.011

中图分类号:R563.1;R733.71

引用信息:

[1]王冉冉,陈婷,李莉霞.1例老年急性淋巴细胞白血病患者继发肺部感染的抗感染治疗实践[J].中国临床药学杂志,2025,34(12):945-947.DOI:10.19577/j.1007-4406.2025.12.011.

发布时间:

2025-12-25

出版时间:

2025-12-25

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文